Mostrando 8 resultados de: 8
Filtros aplicados
Publisher
Revista Latinoamericana de Hipertension(3)
American Journal of Therapeutics(2)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Current Hypertension Reports(1)
F1000Research(1)
Área temáticas
Enfermedades(8)
Farmacología y terapéutica(4)
Fisiología humana(3)
Salud y seguridad personal(3)
Problemas sociales y servicios a grupos(1)
Área de conocimiento
Medicina interna(4)
Biología molecular(1)
Bioquímica(1)
Fisiología(1)
Inmunología(1)
Origen
scopus(8)
Approach to a successful selection of antihypertensive drugs for the patient with atherosclerosis
ArticleAbstract: Coronary heart disease has become a medical and public health issue associated with multiple risk faPalabras claves:ACE inhibitors, atherosclerosis, Coronary heart disease, Hypertension, myocardial infarctionAutores:Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusNon-HDL cholesterol is better than ldl-c at pbkp_redicting atherosclerotic cardiovascular disease risk factors clustering, even in subjects with near-to-normal triglycerides: A report from a venezuelan population
ArticleAbstract: Background: Non-high density lipoprotein cholesterol (non-HDL-c) has emerged as an important tool inPalabras claves:ASCVD, cholesterol, Coronary artery disease, LDL-c, Non-HDL-c, risk factorAutores:de Bravo M.C., D’Addosio R., Graterol M., Graterol R., Hoedebecke K., Lameda V., Martínez M.S., Olivar L.C., Ortega A., Ramírez P., Rastogi S., Rojas E.R., Rojas M., Rojas-Quintero J., Salazar-Vílchez J., Torres W., Valmore Bermúdez, Wilches S.Fuentes:scopusInfection, inflammation and atherosclerotic vascular disease
ReviewAbstract: Cardiovascular disease (CVD) is the leading cause of death in developed countries. The causes of thiPalabras claves:atherosclerosis, Cardiovascular disease, Chlamydia, infection, inflammation, risk factorAutores:Aparicio D., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Martínez Y., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusInsulin resistance and hyperinsulinemia as risk factors for cardiovascular disease
Conference ObjectAbstract: Insulin resistance is defined as a metabolic state in which insulin peripheral effects are diminishePalabras claves:Cardiovascular disease, Hiperinsulinemia, Insulin, Insulin ResistanceAutores:Acosta L., Aparicio D., Arráiz N., Canelón R., Cano R.A., Deisiree S., Finol F., Leal E.M., Linares S., Luti Y., Rojas E.R., Rojas-Quintero J., Valmore BermúdezFuentes:scopusPhysical activity and cardiovascular disease
ReviewAbstract: Coronary artery diseases (CAD) are main cause of morbidity and mortality in western world. MultiplePalabras claves:atherosclerosis, Coronary heart disease, Physical activity, RISK FACTORS, Sedentary life-styleAutores:Aparicio D., Cabrera M., Finol F., Leal E.M., Luis Xavier Enríquez Acosta, Luti Y., Rojas E.R., Toledo A., Valmore Bermúdez, Velasco M.Fuentes:scopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopusTargeting hypertension in patients with cardiorenal metabolic syndrome
ReviewAbstract: Diabetes mellitus coexisting with hypertension is greater than chance alone would pbkp_redict. HyperPalabras claves:Antihypertensive therapy, Blood pressure, Cardiorenal metabolic syndrome, DIABÉTES, Hypertension, Kidney disease, Pharmacologic therapy, RAAS, Reninangiotensin- aldosterone systemAutores:Bolli P., Israili Z.H., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopus